FDA Gives Tentative Approval for Generic Namenda

FDA Gives Tentative Approval for Generic NamendaFDA Gives Tentative Approval for Generic Namenda


(Wall Street Journal) UPDATED 2010-01-06

The U.S. Food and Drug Administration has given the Indian company Wockhardt Ltd. tentative approval to sell a generic form of the Alzheimer's drug Namenda. Wockhardt will sell memantine--the generic name of the drug--in 5 milligram and 10 mg doses.